These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7380179

  • 21. Pathogenesis of ascites in cirrhosis.
    Arroyo V, Badalamenti S, Ginès P.
    Minerva Med; 1987 May 31; 78(10):645-50. PubMed ID: 3587709
    [No Abstract] [Full Text] [Related]

  • 22. Influence of mechanical factors on ascites formation in hepatic cirrhosis.
    Witte MH, Witte CL.
    Lymphology; 1969 Sep 31; 2(3):89-91. PubMed ID: 5357967
    [No Abstract] [Full Text] [Related]

  • 23. Fluid and electrolyte management of ascites in patients with cirrhosis.
    Bass M.
    Crit Care Nurs Clin North Am; 1998 Dec 31; 10(4):459-67. PubMed ID: 10326425
    [Abstract] [Full Text] [Related]

  • 24. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
    Borie DC, Vaillant JC, Breton S, Hannoun L.
    Ann Chir; 1999 Dec 31; 53(10):966-72. PubMed ID: 10670142
    [Abstract] [Full Text] [Related]

  • 25. [Natural course and physiopathology of ascites in the cirrhotic patient].
    Bernardi M, Colantoni A, Caraceni P, Sica G, Trevisani F.
    Ann Ital Med Int; 1996 Oct 31; 11 Suppl 2():30S-38S. PubMed ID: 9004818
    [Abstract] [Full Text] [Related]

  • 26. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G, Meyer-Burg J.
    Leber Magen Darm; 1974 Oct 31; 4(6):299-307. PubMed ID: 4373632
    [No Abstract] [Full Text] [Related]

  • 27. Effective plasma oncotic pressure in hepatic cirrhosis and experimental ascites.
    Witte CL, Witte MH, Cole WR, Dumont AE.
    Surg Forum; 1969 Oct 31; 20():378-80. PubMed ID: 5383090
    [No Abstract] [Full Text] [Related]

  • 28. Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
    Onuigbo MA, Ozoh JO, Nusiem CA, Onyeagocha AC, Nwaneri O, Offodile AA, Ijoma CK.
    Cent Afr J Med; 1991 Aug 31; 37(8):244-7. PubMed ID: 1807797
    [Abstract] [Full Text] [Related]

  • 29. [Pathophysiology of portal hypertension and mechanisms of sodium and water retention in cirrhosis].
    Garini G, Delsante M, Iannuzzella F.
    Recenti Prog Med; 2011 Mar 31; 102(3):134-40. PubMed ID: 21572486
    [Abstract] [Full Text] [Related]

  • 30. Plasma-to-ascitic fluid transport rate of albumin in patients with decompensated cirrhosis. Relation to intraperitoneal albumin.
    Henriksen JH, Ring-Larsen H, Lassen NA, Parving HH, Winkler K.
    Clin Physiol; 1983 Oct 31; 3(5):423-31. PubMed ID: 6685594
    [Abstract] [Full Text] [Related]

  • 31. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Oct 31; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 32. [The role of portal hypertension and colloid-osmotic blood pressure in the pathogenesis of ascitis in patients with hepatic cyrrhosis].
    Kotiv BN, Basov SP.
    Klin Med (Mosk); 2006 Oct 31; 84(3):46-9. PubMed ID: 16758923
    [Abstract] [Full Text] [Related]

  • 33. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.
    Dittrich S, Yordi LM, de Mattos AA.
    Hepatogastroenterology; 2001 Oct 31; 48(37):166-8. PubMed ID: 11268957
    [Abstract] [Full Text] [Related]

  • 34. Ascites: diagnosis and management.
    Hou W, Sanyal AJ.
    Med Clin North Am; 2009 Jul 31; 93(4):801-17, vii. PubMed ID: 19577115
    [Abstract] [Full Text] [Related]

  • 35. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites.
    Cárdenas A, Arroyo V.
    Best Pract Res Clin Endocrinol Metab; 2003 Dec 31; 17(4):607-22. PubMed ID: 14687592
    [Abstract] [Full Text] [Related]

  • 36. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P, Laffi G, La Villa G, Raggi VC.
    Ann Ital Med Int; 1999 Dec 31; 14(4):264-84. PubMed ID: 10638019
    [Abstract] [Full Text] [Related]

  • 37. Mechanism of sodium retention and ascites formation in cirrhosis.
    Arroyo V, Ginès P.
    J Hepatol; 1993 Dec 31; 17 Suppl 2():S24-8. PubMed ID: 8491967
    [Abstract] [Full Text] [Related]

  • 38. [Chylous ascites in cirrhotic and non-cirrhotic patients].
    Casafont F, López-Arias MJ, Crespo J, Dueñas C, Sánchez-Antolín G, Rivero M, Pons Romero F.
    Gastroenterol Hepatol; 1997 Dec 31; 20(6):291-4. PubMed ID: 9296843
    [Abstract] [Full Text] [Related]

  • 39. Role of peritoneal absorption in ascites.
    Luttwak EM, Fabian RP, Mordochovich D.
    Surg Gynecol Obstet; 1975 Nov 31; 141(5):693-8. PubMed ID: 1198302
    [Abstract] [Full Text] [Related]

  • 40. Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
    Navasa M, Rodés J.
    Semin Gastrointest Dis; 1997 Oct 31; 8(4):200-9. PubMed ID: 9360284
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.